Please Wait
Applying Filters...
menu
    • menu
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Padeliporfin

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Impact Biotech To Present Padeliporfin VTP Data At AUA & ASCO
    Impact Biotech To Present Padeliporfin VTP Data At AUA & ASCO

    21 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/21/3278133/0/en/impact-biotech-announces-upcoming-data-presentations-for-padeliporfin-vtp-at-aua-and-asco-2026.html

    GLOBENEWSWIRE
    21 Apr 2026
    Share Share
    Impact Bio Presents Padeliporfin VTP Phase 1 Data In LA-PDAC
    Impact Bio Presents Padeliporfin VTP Phase 1 Data In LA-PDAC

    13 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/13/3272459/0/en/ImPact-Biotech-Presents-Preliminary-Data-from-Phase-1-Study-of-Padeliporfin-VTP-in-LA-PDAC-at-SIR-2026-and-Provides-Strategic-Business-Update.html

    GLOBENEWSWIRE
    13 Apr 2026
    Share Share
    Impact Bio Unveils Phase 3 Padeliporfin VTP Data In LG UTUC
    Impact Bio Unveils Phase 3 Padeliporfin VTP Data In LG UTUC

    04 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/04/3200305/0/en/ImPact-Biotech-Presents-Updated-Preliminary-Data-from-Phase-3-ENLIGHTED-Study-of-Padeliporfin-VTP-in-LG-UTUC-at-SUO-2025.html

    GLOBENEWSWIRE
    04 Dec 2025
    Share Share
    Impact Biotech Presents ENLIGHTED Phase 3 Data at SUO 2025
    Impact Biotech Presents ENLIGHTED Phase 3 Data at SUO 2025

    19 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/19/3191416/0/en/ImPact-Biotech-to-Present-Updated-Interim-Phase-3-Data-from-ENLIGHTED-Study-of-Padeliporfin-VTP-in-Low-Grade-UTUC-at-SUO-2025.html

    GLOBENEWSWIRE
    19 Nov 2025
    Share Share
    ImPact Biotech Presents Updated Padeliporfin VTP Data at AUA 2025
    ImPact Biotech Presents Updated Padeliporfin VTP Data at AUA 2025

    28 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/28/3069134/0/en/ImPact-Biotech-Presents-Updated-Efficacy-Data-from-Evaluation-of-Padeliporfin-VTP-in-LG-UTUC-and-Intermediate-Risk-Prostate-Cancer-at-AUA-2025.html

    GLOBENEWSWIRE
    28 Apr 2025
    Share Share
    ImPact Biotech Presents New Data on Padeliporfin VTP at AUA 2025
    ImPact Biotech Presents New Data on Padeliporfin VTP at AUA 2025

    11 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/11/3060047/0/en/ImPact-Biotech-Announces-New-Data-Presentations-at-AUA-2025-Highlighting-Safety-and-Efficacy-of-Padeliporfin-VTP.html

    GLOBENEWSWIRE
    11 Apr 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.